Literature DB >> 22759512

In silico analysis of DosR regulon proteins of Mycobacterium tuberculosis.

Suganya Selvaraj1, Vaishnavi Sambandam, Dipasri Sardar, Sharmila Anishetty.   

Abstract

One of the challenges faced by Mycobacterium tuberculosis (M. tuberculosis) in dormancy is hypoxia. DosR/DevR of M. tuberculosis is a two component dormancy survival response regulator which induces the expression of 48 genes. In this study, we have used DosR regulon proteins of M. tuberculosis H37Rv as the query set and performed a comprehensive homology search against the non-redundant database. Homologs were found in environmental mycobacteria, environmental bacteria and archaebacteria. Analysis of genomic context of DosR regulon revealed that they are distributed as nine blocks in the genome of M. tuberculosis with many transposases and integrases in their vicinity. Further, we classified DosR regulon proteins into eight functional categories. One of the hypothetical proteins Rv1998c could probably be a methylisocitrate lyase or a phosphonomutase. Another hypothetical protein, Rv0572 was found only in mycobacteria. Insights gained in this study can potentially aid in the development of novel therapeutic interventions.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22759512     DOI: 10.1016/j.gene.2012.06.033

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

Review 1.  The emerging complexity of the tRNA world: mammalian tRNAs beyond protein synthesis.

Authors:  Paul Schimmel
Journal:  Nat Rev Mol Cell Biol       Date:  2017-09-06       Impact factor: 94.444

2.  Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus.

Authors:  Juan Manuel Belardinelli; Deepshikha Verma; Wei Li; Charlotte Avanzi; Crystal J Wiersma; John T Williams; Benjamin K Johnson; Matthew Zimmerman; Nicholas Whittel; Bhanupriya Angala; Han Wang; Victoria Jones; Véronique Dartois; Vinicius C N de Moura; Mercedes Gonzalez-Juarrero; Camron Pearce; Alan R Schenkel; Kenneth C Malcolm; Jerry A Nick; Susan A Charman; Timothy N C Wells; Brendan K Podell; Jonathan L Vennerstrom; Diane J Ordway; Robert B Abramovitch; Mary Jackson
Journal:  Sci Transl Med       Date:  2022-02-23       Impact factor: 19.319

3.  Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.

Authors:  Xiaochun Wang; Jingyan Zhang; Jinping Liang; Ying Zhang; Xindong Teng; Xuefeng Yuan; Xionglin Fan
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

4.  Proteome analysis of the Mycobacterium tuberculosis Beijing B0/W148 cluster.

Authors:  Julia Bespyatykh; Egor Shitikov; Ivan Butenko; Ilya Altukhov; Dmitry Alexeev; Igor Mokrousov; Marine Dogonadze; Viacheslav Zhuravlev; Peter Yablonsky; Elena Ilina; Vadim Govorun
Journal:  Sci Rep       Date:  2016-06-30       Impact factor: 4.379

5.  OsdR of Streptomyces coelicolor and the Dormancy Regulator DevR of Mycobacterium tuberculosis Control Overlapping Regulons.

Authors:  Mia Urem; Teunke van Rossum; Giselda Bucca; Geri F Moolenaar; Emma Laing; Magda A Świątek-Połatyńska; Joost Willemse; Elodie Tenconi; Sébastien Rigali; Nora Goosen; Colin P Smith; Gilles P van Wezel
Journal:  mSystems       Date:  2016-05-03       Impact factor: 6.496

6.  A temporal proteome dynamics study reveals the molecular basis of induced phenotypic resistance in Mycobacterium smegmatis at sub-lethal rifampicin concentrations.

Authors:  Alexander D Giddey; Elise de Kock; Kehilwe C Nakedi; Shaun Garnett; Andrew J M Nel; Nelson C Soares; Jonathan M Blackburn
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

Review 7.  Mycobacterial Dormancy Systems and Host Responses in Tuberculosis.

Authors:  Vidyullatha Peddireddy; Sankara Narayana Doddam; Niyaz Ahmed
Journal:  Front Immunol       Date:  2017-02-15       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.